US Patent Issued to Celgene Quanticel Research on Sept. 8 for "Process for the preparation of bromodomain inhibitor" (British, American Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,183, issued on Sept. 8, was assigned to Celgene Quanticel Research Inc. (San Diego).

"Process for the preparation of bromodomain inhibitor" was invented by John Fitzgerald Traverse (Summit, N.J.), Kelvin Hin-Yeong Yong (Summit, N.J.), Antonio Christian Ferretti (Summit, N.J.), Hekla Alite (Carteret, N.J.), Jonathan Moseley (Bristol, Great Britain), Antonio Maria Ruda (Cardiff, Great Britain), David Primer (Summit, N.J.) and Steven Philp (Abingdon, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides processes of synthesis and purification of a bromodomain inhibitor, Compound 1, which compound includes crystalli...